Myeloproliferative Neoplasm with Eosinophilia and T-lymphoblastic Lymphoma with ETV6-LYN Gene Fusion

Overview

Journal Blood Cancer J

Date 2016 Apr 9

PMID 27058227

Citations 8

Authors

N Telford

S Alexander

O J McGinn

M Williams

K M Wood

A Bloor

V Saha

Affiliations

Soon will be listed here.

Citing Articles

Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis.

Nguyen L, Saha A, Kuykendall A, Zhang L Cancers (Basel). 2024; 16(7).

PMID: 38611061 PMC: 11011008. DOI: 10.3390/cancers16071383.

Hematological Neoplasms with Eosinophilia.

Morales-Camacho R, Caballero-Velazquez T, Borrero J, Bernal R, Prats-Martin C Cancers (Basel). 2024; 16(2).

PMID: 38254826 PMC: 10814743. DOI: 10.3390/cancers16020337.

Myeloid and lymphoid neoplasm with novel complex translocation: unusual case report with T-lymphoblastic lymphoma, myeloid hyperplasia, eosinophilia, basophilia, and t(1;8;10)( (p31;q24;q11.2).

Aljabry M J Hematop. 2024; 16(1):27-31.

PMID: 38175368 DOI: 10.1007/s12308-022-00528-1.

Case Report: Identification of a novel transcript with promyelocytic phenotype and mutation in acute myeloid leukemia.

Hu C, Dai Q, Zhang R, Yang H, Wang M, Gu K Front Oncol. 2023; 13:1322403.

PMID: 38107067 PMC: 10722158. DOI: 10.3389/fonc.2023.1322403.

Myeloid/Lymphoid Neoplasms with Fusion Gene: A Rare Case of Poor Response to Imatinib and Possible Transformation Mechanisms from Myeloid Neoplasms of Bone Marrow to T-Cell Lymphoblastic Lymphoma Invasion in Lymph Nodes.

Gou Y, Tang Y, Liu S, Cheng S, Deng X, Wen Q J Inflamm Res. 2023; 16:5163-5170.

PMID: 38026242 PMC: 10649033. DOI: 10.2147/JIR.S427995.

References

Tanaka H, Takeuchi M, Takeda Y, Sakai S, Abe D, Ohwada C . Identification of a novel TEL-Lyn fusion gene in primary myelofibrosis. Leukemia. 2009; 24(1):197-200. DOI: 10.1038/leu.2009.167. View

Dos Santos C, McDonald T, Ho Y, Liu H, Lin A, Forman S . The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents. Blood. 2013; 122(11):1900-13. PMC: 4968345. DOI: 10.1182/blood-2012-11-466425. View

Ingley E . Functions of the Lyn tyrosine kinase in health and disease. Cell Commun Signal. 2012; 10(1):21. PMC: 3464935. DOI: 10.1186/1478-811X-10-21. View

De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris M, Basinko A, De Braekeleer M . ETV6 fusion genes in hematological malignancies: a review. Leuk Res. 2012; 36(8):945-61. DOI: 10.1016/j.leukres.2012.04.010. View

Tefferi A . Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1. J Cell Mol Med. 2009; 13(2):215-37. PMC: 3823350. DOI: 10.1111/j.1582-4934.2008.00559.x. View

Bohlander S . ETV6: a versatile player in leukemogenesis. Semin Cancer Biol. 2005; 15(3):162-74. DOI: 10.1016/j.semcancer.2005.01.008. View

Wu J, Meng F, Lu H, Kong L, Bornmann W, Peng Z . Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells. Blood. 2008; 111(7):3821-9. PMC: 2275035. DOI: 10.1182/blood-2007-08-109330. View

Abe A, Emi N, Kanie T, Imagama S, Kuno Y, Takahashi M . Expression cloning of oligomerization-activated genes with cell-proliferating potency by pseudotype retrovirus vector. Biochem Biophys Res Commun. 2004; 320(3):920-6. DOI: 10.1016/j.bbrc.2004.06.040. View

Tefferi A, Thiele J, Vannucchi A, Barbui T . An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms. Leukemia. 2014; 28(7):1407-13. DOI: 10.1038/leu.2014.35. View

10.

Shvidel L, Sigler E, Vorst E, Feldberg E, Voskoboinic N, Shtalrid M . A novel cytogenetic aberration found in stem cell leukemia/lymphoma syndrome. Leukemia. 2007; 22(3):644-6. DOI: 10.1038/sj.leu.2404942. View

11.

Strehl S, Nebral K, Konig M, Harbott J, Strobl H, Ratei R . ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations. Clin Cancer Res. 2008; 14(4):977-83. DOI: 10.1158/1078-0432.CCR-07-4022. View

12.

Takeda Y, Nakaseko C, Tanaka H, Takeuchi M, Yui M, Saraya A . Direct activation of STAT5 by ETV6-LYN fusion protein promotes induction of myeloproliferative neoplasm with myelofibrosis. Br J Haematol. 2011; 153(5):589-98. PMC: 3091948. DOI: 10.1111/j.1365-2141.2011.08663.x. View

13.

Dos Santos C, Demur C, Bardet V, Prade-Houdellier N, Payrastre B, Recher C . A critical role for Lyn in acute myeloid leukemia. Blood. 2007; 111(4):2269-79. DOI: 10.1182/blood-2007-04-082099. View